Kombiglyze

Country: New Zealand

Language: English

Source: Medsafe (Medicines Safety Authority)

Active ingredient:

Metformin hydrochloride 1000mg;  ; Saxagliptin 2.5mg

Available from:

AstraZeneca Limited

INN (International Name):

Metformin hydrochloride 1000 mg

Dosage:

2.5mg/1000mg

Pharmaceutical form:

Film coated tablet

Composition:

Active: Metformin hydrochloride 1000mg   Saxagliptin 2.5mg Excipient: Hydrochloric acid Magnesium stearate Opacode blue S-1-10619 Opadry II yellow 85F92209 Opadry white 85F18422 Povidone Purified water

Prescription type:

Prescription

Manufactured by:

Merck Sante SAS

Therapeutic indications:

Kombiglyze is indicated as an adjunct to diet & exercise to improve glycaemic control in adults with type 2 diabetes mellitus when treatment with both saxagliptin & metformin is appropriate.

Product summary:

Package - Contents - Shelf Life: Blister pack, - 56 tablets - 2 years from date of manufacture stored at or below 25°C

Authorization date:

2013-12-12